The infiltration of NOS2+ and CD163+ cells was related to clinicopathologic and molecular variables, as well as prognosis, both in the complete CRC cohort and in subgroups of CRC defined by MSI screening status and CIMP status. The gene discussed is CD163; the disease is colorectal carcinoma.